Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,961.11 -1,023.30 (-1.60%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 235.95 |
| Open | 236.59 |
| Bid | 233.80 x 200 |
| Ask | 234.01 x 100 |
| Day's range | 233.64 - 237.53 |
| 52-week range | 204.44 - 261.54 |
| Volume | |
| Avg. volume | 467,628 |
| Market cap | 11.005B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 11.80 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.